Garcia A - Search Results

1

Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.

Vergote IB, Garcia A, Micha J, Pippitt C, Bendell J, Spitz D, Reed N, Dark G, Fracasso PM, Ibrahim EN, Armenio VA, Duska L, Poole C, Gennigens C, Dirix LY, Leung AC, Zhao C, Soufi-Mahjoubi R, Rustin G. Vergote IB, et al. Among authors: garcia a. J Clin Oncol. 2013 Nov 10;31(32):4060-6. doi: 10.1200/JCO.2012.45.1278. Epub 2013 Sep 30. J Clin Oncol. 2013. PMID: 24081946 Free PMC article. Clinical Trial.

2

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

Muggia FM, Hainsworth JD, Jeffers S, Miller P, Groshen S, Tan M, Roman L, Uziely B, Muderspach L, Garcia A, Burnett A, Greco FA, Morrow CP, Paradiso LJ, Liang LJ. Muggia FM, et al. Among authors: garcia a. J Clin Oncol. 1997 Mar;15(3):987-93. doi: 10.1200/JCO.1997.15.3.987. J Clin Oncol. 1997. PMID: 9060537 Clinical Trial.

3

Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors.

Garcia AA, Keren-Rosenberg S, Parimoo D, Rogers M, Jeffers S, Koda R, Muggia FM. Garcia AA, et al. J Clin Oncol. 1998 Sep;16(9):2959-63. doi: 10.1200/JCO.1998.16.9.2959. J Clin Oncol. 1998. PMID: 9738564 Clinical Trial.

4

A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas.

Garcia AA, Kempf RA, Rogers M, Muggia FM. Garcia AA, et al. Ann Oncol. 1998 Oct;9(10):1131-3. doi: 10.1023/a:1008439013169. Ann Oncol. 1998. PMID: 9834828 Free article. Clinical Trial.

5

A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.

Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow CP. Burnett AF, et al. Among authors: garcia aa. Gynecol Oncol. 2000 Jan;76(1):63-6. doi: 10.1006/gyno.1999.5657. Gynecol Oncol. 2000. PMID: 10620443 Clinical Trial.

6

Phase II study of liposomal doxorubicin in advanced gynecologic cancers.

Israel VP, Garcia AA, Roman L, Muderspach L, Burnett A, Jeffers S, Muggia FM. Israel VP, et al. Among authors: garcia aa. Gynecol Oncol. 2000 Aug;78(2):143-7. doi: 10.1006/gyno.2000.5819. Gynecol Oncol. 2000. PMID: 10926793 Clinical Trial.

7

Salvage therapy for ovarian cancer.

Garcia AA. Garcia AA. Curr Oncol Rep. 1999 Sep;1(1):64-70. doi: 10.1007/s11912-999-0012-8. Curr Oncol Rep. 1999. PMID: 11122800 Review.

8

Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.

Garcia AA, Leichman CG, Lenz HJ, Baranda J, Lujan R, Casagrande Y, Leichman L. Garcia AA, et al. Jpn J Clin Oncol. 2001 Jun;31(6):275-8. doi: 10.1093/jjco/hye060. Jpn J Clin Oncol. 2001. PMID: 11463806 Clinical Trial.

9

Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.

Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. Garcia AA, et al. Gynecol Oncol. 2004 May;93(2):493-8. doi: 10.1016/j.ygyno.2004.02.007. Gynecol Oncol. 2004. PMID: 15099968 Clinical Trial.

10

Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.

Garcia AA, Leichman L, Baranda J, Pandit L, Lenz HJ, Leichman CG. Garcia AA, et al. Int J Gastrointest Cancer. 2003;34(2-3):79-86. doi: 10.1385/IJGC:34:2-3:079. Int J Gastrointest Cancer. 2003. PMID: 15361639 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,212 results

Search Page